Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or Older

NCT03878446 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT03878446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or Older
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 4, 2019
Completion date
December 23, 2026
Enrollment
62 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

short stature children born small for gestational age (sga)